Gilead Sciences, Inc Unsponsored Brazilian Depository Receipt Repr 1/2 Sh
No trades
Trade ideas
Bear swing on GILDREALLY nice bull inside candle at a nice high. After a run up.. This would be VERY interesting short. I have zero issue losing 1R on this trade. However, I did mention in a Forbes article that big pharma is PROB going to be the best performing asset / sector From Oct 2022 to April 2023 (mid term election cycle)
Buy $GILD - NRPicks 25 FebGilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes drugs in areas of unmet medical need such as human immunodeficiency virus (HIV) in the United States, Europe and internationally.
Revenue TTM 27.3B
Net Income TTM 6.2B
EBITDA TTM 12.5B
Debt/EBITDA TTM 2.5x
EBITDA Margin 45.9%
Net Margin 22.8%
Shorting Gilead. GILDIndeed. B Wave in a zigzag form appears to be completed. We are going down to one extent to another.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Confirmation level, where relevant, is a pink dotted, finite line. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe.
Gilead Sciences: Boom Times Ahead? - Potential Run to +$110 areaNASDAQ:GILD
Early Long Idea on Gilead Sciences
Gilead has navigated 2/3rds of a huge arc that has been forming since 2015, and the arc is beginning to slope vertical.
Price navigated the yellow pitchfork on the way down, and now is beginning to be directed by the purple upsloping fork.
Weekly Stoch RSI is approaching oversold levels.
I will wait for a momentum signal or another strong arc retest before going long with a long dated call / LEAP.
Just an idea right now, with a lot of upside.






















